Hemington Wealth Management Corcept Therapeutics Inc Transaction History
Hemington Wealth Management
- $398 Million
- Q4 2024
A detailed history of Hemington Wealth Management transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hemington Wealth Management holds 74 shares of CORT stock, worth $4,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74
Previous 39
89.74%
Holding current value
$4,952
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
355Shares Held
86.2MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$1.11 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$670 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$542 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$436 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$255 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.17B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...